2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Length of Stay: new trials by email Literature Review of Length of Stay trials Research Report on Length of Stay
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Limited Versus Extended Trophic Feeding (LET-FEED) Trial Limited Trophic Feeds (1 day of trophic feeds), Extended Trophic Feeds (3 days of trophics) - Sepsis, Length of Stay | Phase 2 / Phase 3 | Recruiting | University of Washington | 350 | 2025-07-03 | 2026-08-17 |
| Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer Laparoscopic Surgery for Colorectal Cancer, XELOX Chemotherapy, mFolfox6 chemotherapy - Length of Stay, Complications | Phase 3 | Completed | Zhejiang University | 374 | 2010-03-01 | 2017-04-06 |
| Unnecessary, Avoidable Lengths of Stay: a Strategy for Clinician Empowerment and Effectiveness Evaluation Multicomponent strategy to reduce avoidable length of stay, No intervention - Hospitalization, Length of Stay | Phase 3 | Completed | Azienda Ospedaliero-Universitaria di Parma | 3862 | 2008-02-01 | 2018-07-03 |
Drug-Related Side Effects and Adverse Reactions (1) · Premature Birth (1) · Sepsis (1)
Chemically-Induced Disorders (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Infections (1) · Inflammation (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pregnancy Complications (1) · Systemic Inflammatory Response Syndrome (1) · Urogenital Diseases (1)
Capecitabine (1) · Laparoscopy (1) · Oxaliplatin (1)
Azienda Ospedaliero-Universitaria di Parma (1) · University of Washington (1) · Zhejiang University (1)
China (1) · Italy (1) · United States (1)
Caterina Caminiti (1) · Gregory C Valentine (1) · Ke-Feng Ding, PhD/MD (1)